Using Twitter was not his idea. But after being inspired by peers who were live-tweeting at the 2014 American Society of Hematology Annual Meeting, Cleveland Clinic hematologist Aaron Gerds, MD, has learned that “Twitter isn’t just for millennials.”
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Since then, he’s discovered how Twitter can help him save time in keeping up with the latest developments in his specialty, myeloproliferative neoplasms (MPN). (He follows hematologists, patients and advocacy groups that tweet with the hashtag #MPNSM.) And he’s opened a new line of communication with patients who follow him @AaronGerds.
He shares his perspectives — including tips for physicians nervous about signing up for a Twitter account — in ASH Clinical News.
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust